BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 30073537)

  • 1. Probing the Function of Oncohistones Using Mutant Transgenes and Knock-In Mutations.
    Fang D; Wang H; Zhang Z
    Methods Mol Biol; 2018; 1832():339-356. PubMed ID: 30073537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone deposition pathways determine the chromatin landscapes of H3.1 and H3.3 K27M oncohistones.
    Sarthy JF; Meers MP; Janssens DH; Henikoff JG; Feldman H; Paddison PJ; Lockwood CM; Vitanza NA; Olson JM; Ahmad K; Henikoff S
    Elife; 2020 Sep; 9():. PubMed ID: 32902381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncohistones: drivers of pediatric cancers.
    Mohammad F; Helin K
    Genes Dev; 2017 Dec; 31(23-24):2313-2324. PubMed ID: 29352018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone H3K27M Mutation in Brain Tumors.
    El-Hashash AHK
    Adv Exp Med Biol; 2021; 1283():43-52. PubMed ID: 33155136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of cancer: Oncohistones in action.
    Qiu L; Hu X; Jing Q; Zeng X; Chan KM; Han J
    J Genet Genomics; 2018 May; 45(5):227-236. PubMed ID: 29804713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The dark side of histones: genomic organization and role of oncohistones in cancer.
    Amatori S; Tavolaro S; Gambardella S; Fanelli M
    Clin Epigenetics; 2021 Apr; 13(1):71. PubMed ID: 33827674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone mutations in cancer.
    Espinoza Pereira KN; Shan J; Licht JD; Bennett RL
    Biochem Soc Trans; 2023 Oct; 51(5):1749-1763. PubMed ID: 37721138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Creation of knock out and knock in mice by CRISPR/Cas9 to validate candidate genes for human male infertility, interest, difficulties and feasibility.
    Kherraf ZE; Conne B; Amiri-Yekta A; Kent MC; Coutton C; Escoffier J; Nef S; Arnoult C; Ray PF
    Mol Cell Endocrinol; 2018 Jun; 468():70-80. PubMed ID: 29522859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncohistones: a roadmap to stalled development.
    Deshmukh S; Ptack A; Krug B; Jabado N
    FEBS J; 2022 Mar; 289(5):1315-1328. PubMed ID: 33969633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncohistones: Hijacking the histone code.
    Sahu V; Lu C
    Annu Rev Cancer Biol; 2022 Apr; 6():293-312. PubMed ID: 36589281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancing targeted transgene knock-in by donor recruitment.
    Jiao G; Wang C; Chen Y; Dai M; Zhang Y; Li W
    Cell Prolif; 2022 Jan; 55(1):e13163. PubMed ID: 34854166
    [No Abstract]   [Full Text] [Related]  

  • 12. S-adenosyl methionine is necessary for inhibition of the methyltransferase G9a by the lysine 9 to methionine mutation on histone H3.
    Jayaram H; Hoelper D; Jain SU; Cantone N; Lundgren SM; Poy F; Allis CD; Cummings R; Bellon S; Lewis PW
    Proc Natl Acad Sci U S A; 2016 May; 113(22):6182-7. PubMed ID: 27185940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR/Cas-mediated knock-in via non-homologous end-joining in the crustacean Daphnia magna.
    Kumagai H; Nakanishi T; Matsuura T; Kato Y; Watanabe H
    PLoS One; 2017; 12(10):e0186112. PubMed ID: 29045453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient generation of Rosa26 knock-in mice using CRISPR/Cas9 in C57BL/6 zygotes.
    Chu VT; Weber T; Graf R; Sommermann T; Petsch K; Sack U; Volchkov P; Rajewsky K; Kühn R
    BMC Biotechnol; 2016 Jan; 16():4. PubMed ID: 26772810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted knock-in of an scFv-Fc antibody gene into the hprt locus of Chinese hamster ovary cells using CRISPR/Cas9 and CRIS-PITCh systems.
    Kawabe Y; Komatsu S; Komatsu S; Murakami M; Ito A; Sakuma T; Nakamura T; Yamamoto T; Kamihira M
    J Biosci Bioeng; 2018 May; 125(5):599-605. PubMed ID: 29295784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone H2B Mutations in Cancer.
    Wan YCE; Chan KM
    Biomedicines; 2021 Jun; 9(6):. PubMed ID: 34205231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone Mutations and Bone Cancers.
    Taylor EL; Westendorf JJ
    Adv Exp Med Biol; 2021; 1283():53-62. PubMed ID: 33155137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient CRISPR-Cas9-mediated generation of knockin human pluripotent stem cells lacking undesired mutations at the targeted locus.
    Merkle FT; Neuhausser WM; Santos D; Valen E; Gagnon JA; Maas K; Sandoe J; Schier AF; Eggan K
    Cell Rep; 2015 May; 11(6):875-883. PubMed ID: 25937281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Rapid and Cheap Methodology for CRISPR/Cas9 Zebrafish Mutant Screening.
    D'Agostino Y; Locascio A; Ristoratore F; Sordino P; Spagnuolo A; Borra M; D'Aniello S
    Mol Biotechnol; 2016 Jan; 58(1):73-8. PubMed ID: 26676479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone isoforms and the oncohistone code.
    Flaus A; Downs JA; Owen-Hughes T
    Curr Opin Genet Dev; 2021 Apr; 67():61-66. PubMed ID: 33285512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.